TWD 5.04
(-1.95%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | -21.06 Million USD | 28.01% |
2022 | -29.26 Million USD | -268.74% |
2021 | 17.34 Million USD | -86.83% |
2020 | 131.71 Million USD | 11234.85% |
2019 | 1.16 Million USD | 27.13% |
2018 | 914 Thousand USD | 3.51% |
2017 | 883 Thousand USD | -13.52% |
2016 | 1.02 Million USD | 92.64% |
2015 | 530 Thousand USD | 38.38% |
2014 | 383 Thousand USD | -37.52% |
2013 | 613 Thousand USD | -53.17% |
2012 | 1.3 Million USD | -24.03% |
2011 | 1.72 Million USD | 22.98% |
2010 | 1.4 Million USD | -21.6% |
2009 | 1.78 Million USD | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q2 | -3.87 Million USD | 75.31% |
2023 FY | -21.06 Million USD | 28.01% |
2023 Q2 | -5.35 Million USD | 78.48% |
2023 Q4 | -15.7 Million USD | -193.17% |
2022 Q2 | -3.69 Million USD | -114.56% |
2022 FY | -29.26 Million USD | -268.74% |
2022 Q4 | -24.89 Million USD | -573.07% |
2021 Q4 | -1.72 Million USD | -109.04% |
2021 Q2 | 19.06 Million USD | -79.46% |
2021 FY | 17.34 Million USD | -86.83% |
2020 Q2 | 38.89 Million USD | 4905.15% |
2020 Q4 | 92.82 Million USD | 138.68% |
2020 FY | 131.71 Million USD | 11234.85% |
2019 Q4 | 777 Thousand USD | 101.82% |
2019 Q2 | 385 Thousand USD | -31.37% |
2019 FY | 1.16 Million USD | 27.13% |
2018 Q4 | 561 Thousand USD | 58.92% |
2018 FY | 914 Thousand USD | 3.51% |
2018 Q2 | 353 Thousand USD | 3.52% |
2017 Q4 | 341 Thousand USD | -37.08% |
2017 Q2 | 542 Thousand USD | 1.5% |
2017 FY | 883 Thousand USD | -13.52% |
2016 FY | 1.02 Million USD | 92.64% |
2016 Q4 | 534 Thousand USD | 9.65% |
2016 Q2 | 487 Thousand USD | 126.51% |
2015 FY | 530 Thousand USD | 38.38% |
2015 Q4 | 215 Thousand USD | -31.75% |
2015 Q2 | 315 Thousand USD | 146.09% |
2014 Q2 | 255 Thousand USD | 222.6% |
2014 FY | 383 Thousand USD | -37.52% |
2014 Q4 | 128 Thousand USD | -49.8% |
2013 Q4 | -208 Thousand USD | -125.33% |
2013 FY | 613 Thousand USD | -53.17% |
2013 Q2 | 821 Thousand USD | 0.0% |
2012 Q4 | - USD | 0.0% |
2012 FY | 1.3 Million USD | -24.03% |
2011 Q2 | - USD | 0.0% |
2011 FY | 1.72 Million USD | 22.98% |
2011 Q4 | - USD | 0.0% |
2010 FY | 1.4 Million USD | -21.6% |
2010 Q4 | - USD | 0.0% |
2009 Q4 | - USD | 0.0% |
2009 FY | 1.78 Million USD | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Nang Kuang Pharmaceutical Co., Ltd. | 198.4 Million TWD | 110.617% |
Maxigen Biotech Inc. | 165.82 Million TWD | 112.704% |
SciVision Biotech Inc. | 177.9 Million TWD | 111.841% |
Bionime Corporation | 6.2 Million TWD | 439.282% |
Pegavision Corporation | 1.65 Billion TWD | 101.272% |
Visco Vision Inc. | 301.61 Million TWD | 106.984% |